Universal-Beteiligungs- und Servicegesellschaft

Universal-Beteiligungs- und Servicegesellschaft’s Acadia Pharmaceuticals ACAD Stock Holding History

Universal-Beteiligungs- und Servicegesellschaft’s Portfolio ACAD Stock Details ACAD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$736K	Sell	33,079 -29,909	-47%	-$715K	﹤0.01%	1612
2025 Q4	$1.68M	Buy	62,988 +15,894	+34%	+$380K	﹤0.01%	1317
2025 Q3	$1M	Sell	47,094 -64,913	-58%	-$1.54M	﹤0.01%	1549
2025 Q2	$2.42M	Buy	112,007 +5,111	+5%	+$95K	﹤0.01%	1137
2025 Q1	$1.78M	Buy	+106,896	New	+$1.94M	﹤0.01%	1253

Other funds holding ACAD

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

First Trust Advisors

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Dimensional Fund Advisors

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return